BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
20.09.12 Julius Bär reduce Vontobel Research
19.09.12 Adecco SA buy Sarasin Research
18.09.12 UBS halten Independent Research GmbH
18.09.12 Adecco SA buy Vontobel Research
18.09.12 Kühne + Nagel International hold Vontobel Research
17.09.12 ABB (Asea Brown Boveri) halten Independent Research GmbH
17.09.12 Swisscom hold Vontobel Research
17.09.12 ABB (Asea Brown Boveri) outperform Exane-BNP Paribas SA
14.09.12 Nestlé neutral HSBC
14.09.12 Lonza neutral J.P. Morgan Cazenove
14.09.12 ABB (Asea Brown Boveri) sell Deutsche Bank AG
14.09.12 UBS outperform Exane-BNP Paribas SA
13.09.12 ABB (Asea Brown Boveri) buy Citigroup Corp.
13.09.12 Swiss Re overweight J.P. Morgan Cazenove
13.09.12 ABB (Asea Brown Boveri) buy UBS AG
13.09.12 ABB (Asea Brown Boveri) hold Société Générale Group S.A. (SG)
13.09.12 UBS buy Nomura
13.09.12 Novartis reduce Vontobel Research
13.09.12 Holcim hold Vontobel Research
13.09.12 ABB (Asea Brown Boveri) buy Vontobel Research
12.09.12 Novartis neutral J.P. Morgan Cazenove
11.09.12 Givaudan outperform Exane-BNP Paribas SA
11.09.12 Novartis underperform Banc of America Securities-Merrill Lynch
11.09.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
11.09.12 Roche outperform Sanford C. Bernstein and Co., Inc.
10.09.12 Swisscom hold Deutsche Bank AG
10.09.12 Nestlé buy Sarasin Research
10.09.12 Roche buy Banc of America Securities-Merrill Lynch
10.09.12 Nestlé kaufen Norddeutsche Landesbank (Nord/LB)
10.09.12 Geberit hold Vontobel Research
10.09.12 Swisscom hold Vontobel Research
10.09.12 Swiss Re buy Vontobel Research
07.09.12 Roche outperform Exane-BNP Paribas SA
07.09.12 Holcim outperform Exane-BNP Paribas SA
07.09.12 Novartis neutral J.P. Morgan Cazenove
06.09.12 Holcim neutral J.P. Morgan Cazenove
06.09.12 Richemont neutral J.P. Morgan Cazenove
06.09.12 Swiss Re sell Goldman Sachs Group Inc.
06.09.12 Roche overweight J.P. Morgan Cazenove
06.09.12 Novartis neutral Exane-BNP Paribas SA